AML Insights: What’s New in the Field

Discover the key developments in the treatment of acute myeloid leukemia, including the role of menin inhibitors, MRD-guided therapy, and new combination regimens involving chidamide and FLT3-targeted agents. Several studies also address challenges in high-risk patient groups, such as those with TP53 mutations.
Don’t miss these exciting developments!